In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab’s (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. He discusses the science behind the MedTech technology; the progress toward obtaining FDA approval; and, the real potential to develop screening for further neurological conditions. Professor Wang also highlights the strategic collaborations with other prestigious academic institutions.
More From The Market Online
Listen: HotCopper Wire Podcast #050 – Droning on (and on and on…)
In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson crack into why Australian traders are rotating into defensive stocks so heavily
- Isaac McIntyre
- 2 mins
- 11 June 2026 15:59 (AEST)
Paradigm Biopharma completes enrolment in pivotal Phase 3 osteoarthritis trial
Welcome to HotCopper’s latest Watchlist, where we’ve this week been joined by Paradigm Biopharmaceuticals (ASX:PAR) managing director Paul Rennie to talk about
- Isaac McIntyre
- 1 min
- 16 June 2026 14:10 (AEST)
Auravelle Metals advancing Kal Gold targets with soil sampling completed
Auravelle Metals has completed a targeted soil sampling program at the Crown gold project in WA’s…
- Colin Sandell-Hay
- 2 mins
- 18 June 2026 15:33 (AEST)
The ASX Today: Markets fall as US Fed revives rate hike fears; Energy a lone bright spot
The ASX 200 fell after the US Federal Reserve signalled interest rates may need to rise…
- Seja Al Zaidi
- 2 mins
- 18 June 2026 15:41 (AEST)
